Innovotech : The Hospital for Sick Children and St Michael's Hospital to Evaluate bioFILM PA Test

July 29, 2008 - Innovotech Inc. (TSX VENTURE:IOT) is pleased to announce a three year study by the Hospital for Sick Children and St. Michael's Hospital to evaluate bioFILM PA^TM, Innovotech's novel biofilm antimicrobial susceptibility test, in the selection of antibiotics to treat lung infections in cystic fibrosis patients.

"bioFILM PA^TM is a Health Canada registered product, and is therefore available for use by physicians and diagnostic laboratories in the treatment of a host of biofilm respiratory infections" says Dr Bhavin Rawal, Product Manager, Innovotech. "Our early results in cystic fibrosis show promise, so it is appropriate to continue the evaluation of bioFILM PA^TM, particularly with the Hospital for Sick Children and St Michael's Hospital, given their international reputation in this field."... Innovotech's Press Release -